Wed. 3 Apr 2024, 8:32am ET
Benzinga
Biotech, News, General
Multiple clinical trial sites to be opened under collaboration with large network of community-based oncology practices
Acclaim-3 Study Supported by FDA Orphan Drug and Fast Track Designations